login
login

Europe Daily Bulletin No. 7669

4 March 2000
Contents Publication in full By article 35 / 39
ECONOMIC INTERPENETRATION / (eu) vaccines

The German biotechnology company RHEIN BIOTECH acquired an 80% stake in the Korean company GREEN CROSS VACCINE CORP (KOREA GREEN CROSS group) for the equivalent of USD 110 million. This company is the largest maker of Hepatitis B vaccines in the Asian market.

Contents

THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE
ECONOMIC INTERPENETRATION